Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Area
2.2. Study Population
2.3. Serological Assays
2.4. Ethical Considerations
3. Results
3.1. Prevalence of Anti-HEV IgG Antibodies in Genders
3.2. Prevalence of Anti-HEV IgG in Age Groups
3.3. History of Hepatitis B and Hepatitis C Infection
3.4. Household Education
3.5. Employment Status
3.6. Dependency Index
3.7. Source of Drinking Water
3.8. Household Occupancy
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Haffar, S.; Bazerbachi, F.; Lake, J.R. Making the case for the development of a vaccination against hepatitis E virus. Liver Int. 2015, 35, 311–316. [Google Scholar] [CrossRef] [PubMed]
- Dalton, H.R.; Bendall, R.; Ijaz, S.; Banks, M. Hepatitis E: An emerging infection in developed countries. Lancet Infect. Dis. 2008, 8, 698–709. [Google Scholar] [CrossRef]
- Farooqi, H.M.U.; Kang, B.; Khalid, M.A.U.; Salih, A.R.C.; Hyun, K.; Park, S.H.; Huh, D.; Choi, K.H. Real-time monitoring of liver fibrosis through embedded sensors in a microphysiological system. Nano Converg. 2021, 8, 1–12. [Google Scholar] [CrossRef]
- Kausar, F.; Kim, K.-H.; Farooqi, H.M.U.; Farooqi, M.A.; Kaleem, M.; Waqar, R.; Khalil, A.A.K.; Khuda, F.; Abdul Rahim, C.S.; Hyun, K. Evaluation of Antimicrobial and Anticancer Activities of Selected Medicinal Plants of Himalayas, Pakistan. Plants 2021, 11, 48. [Google Scholar] [CrossRef]
- Petrik, J.; Lozano, M.; Seed, C.R.; Faddy, H.M.; Keller, A.J.; Prado Scuracchio, P.S.; Wendel, S.; Andonov, A.; Fearon, M.; Delage, G. Hepatitis E. Vox Sang 2016, 110, 93–130. [Google Scholar] [CrossRef]
- Lhomme, S.; Marion, O.; Abravanel, F.; Izopet, J.; Kamar, N. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J. Clin. Med. 2020, 9, 331. [Google Scholar] [CrossRef] [Green Version]
- Nan, Y.; Zhang, Y.-J. Molecular biology and infection of hepatitis E virus. Front. Microbiol. 2016, 7, 1419. [Google Scholar] [CrossRef]
- Farooqi, H.M.U.; Sammantasinghar, A.; Kausar, F.; Farooqi, M.A.; Chethikkattuveli Salih, A.R.; Hyun, K.; Lim, J.-H.; Khalil, A.A.K.; Mumtaz, A.S.; Choi, K.H. Study of the Anticancer Potential of Plant Extracts Using Liver Tumor Microphysiological System. Life 2022, 12, 135. [Google Scholar] [CrossRef]
- Kennedy, P.T.; Litwin, S.; Dolman, G.E.; Bertoletti, A.; Mason, W.S. Immune tolerant chronic hepatitis B: The unrecognized risks. Viruses 2017, 9, 96. [Google Scholar] [CrossRef]
- Kar, P.; Sengupta, A. A guide to the management of hepatitis E infection during pregnancy. Expert Rev. Gastroenterol. Hepatol. 2019, 13, 205–211. [Google Scholar] [CrossRef]
- Farooqi, H.M.U.; Kim, K.-H.; Kausar, F.; Muhammad, J.; Bukhari, H.; Choi, K.-H. Frequency and Molecular Characterization of Staphylococcus aureus from Placenta of Mothers with Term and Preterm Deliveries. Life 2022, 12, 257. [Google Scholar] [CrossRef] [PubMed]
- Hartl, J.; Wehmeyer, M.H.; Pischke, S. Acute hepatitis E: Two sides of the same coin. Viruses 2016, 8, 299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- CEIC. Pakistan Average Monthly Wages. 2021. Available online: https://www.ceicdata.com/en/pakistan/average-monthly-wages-by-industry (accessed on 24 July 2022).
- Butt, A.S.; Sharif, F. Viral hepatitis in Pakistan: Past, present, and future. Euroasian J. Hepato-Gastroenterol. 2016, 6, 70. [Google Scholar]
- Yasin, S.; Bhatti, T.; Farooqi, M.U.; Mateen, F. Immunologic aspect in diagnosis and treatment of SARS-CoV-2 patients. J. Shifa Tameer E Millat Univ. 2020, 3, 113–121. [Google Scholar]
- Zahid, A.S.; Farooqi, H.M.U.; Ahsan, A.; Farooqi, M.A.; Kausar, F.; Muhammad, J.; Ahmad, A. Comparative Analysis of Antigenic Strength and In vivo Serum Antibodies Concentration of Tetanus Toxoid Vaccine Adsorbed in Pakistan. Saudi J. Biol. Sci. 2022, 29, 103337. [Google Scholar] [CrossRef]
- Rasche, A.; Saqib, M.; Liljander, A.M.; Bornstein, S.; Zohaib, A.; Renneker, S.; Steinhagen, K.; Wernery, R.; Younan, M.; Gluecks, I. Hepatitis E virus infection in dromedaries, north and east Africa, United Arab Emirates, and Pakistan, 1983–2015. Emerg. Infect. Dis. 2016, 22, 1249. [Google Scholar] [CrossRef]
- Farooqi, H.M.U. Liver-on-Chip Development for Pathophysiological Emulation and Drug Toxicity Testing; Jeju National University Graduate School: Jeju, Korea, 2022. [Google Scholar]
- Gallian, P.; Pouchol, E.; Djoudi, R.; Lhomme, S.; Mouna, L.; Gross, S.; Bierling, P.; Assal, A.; Kamar, N.; Mallet, V. Transfusion-transmitted hepatitis E virus infection in France. Transfus. Med. Rev. 2019, 33, 146–153. [Google Scholar] [CrossRef]
- Slot, E.; Zaaijer, H.L.; Molier, M.; Van den Hurk, K.; Prinsze, F.; Hogema, B.M. Meat consumption is a major risk factor for hepatitis E virus infection. PLoS ONE 2017, 12, e0176414. [Google Scholar] [CrossRef] [PubMed]
- Thippornchai, N.; Leaungwutiwong, P.; Kosoltanapiwat, N.; Vuong, C.; Nguyen, K.; Okabayashi, T.; Lee, A. Survey of hepatitis E virus in pork products and pig stools in Nakhon Pathom Province, Thailand. Vet. Med. Sci. 2022. [Google Scholar] [CrossRef]
- Mooij, S.H.; Hogema, B.M.; Tulen, A.D.; van Pelt, W.; Franz, E.; Zaaijer, H.L.; Molier, M.; Hofhuis, A. Risk factors for hepatitis E virus seropositivity in Dutch blood donors. BMC Infect. Dis. 2018, 18, 1–10. [Google Scholar]
- Fuller, S.; Qian, Y. COVID-19 and the gender gap in employment among parents of young children in Canada. Gend. Soc. 2021, 35, 206–217. [Google Scholar] [CrossRef]
- Murhekar, M.V.; Ashok, M.; Kanagasabai, K.; Joshua, V.; Ravi, M.; Sabarinathan, R.; Kirubakaran, B.; Ramachandran, V.; Shete, V.; Gupta, N. Epidemiology of hepatitis A and hepatitis E based on laboratory surveillance data—India, 2014–2017. Am. J. Trop. Med. Hyg. 2018, 99, 1058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nelson, K.E.; Labrique, A.B.; Kmush, B.L. Epidemiology of genotype 1 and 2 hepatitis E virus infections. Cold Spring Harb. Perspect. Med. 2019, 9, a031732. [Google Scholar] [CrossRef]
- Alfonsi, V.; Romanò, L.; Ciccaglione, A.R.; La Rosa, G.; Bruni, R.; Zanetti, A.; Della Libera, S.; Iaconelli, M.; Bagnarelli, P.; Capobianchi, M.R. Hepatitis E in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016. Eurosurveillance 2018, 23, 1700517. [Google Scholar] [CrossRef]
- Kausar, F.; Farooqi, M.-A.; Farooqi, H.-M.-U.; Salih, A.-R.-C.; Khalil, A.-A.-K.; Kang, C.-w.; Mahmoud, M.H.; Batiha, G.-E.-S.; Choi, K.-h.; Mumtaz, A.-S. Phytochemical Investigation, Antimicrobial, Antioxidant and Anticancer Activities of Acer cappadocicum Gled. Life 2021, 11, 656. [Google Scholar] [CrossRef] [PubMed]
- Sayed, I.M.; El-Mokhtar, M.A.; Mahmoud, M.A.R.; Elkhawaga, A.A.; Gaber, S.; Seddek, N.H.; Abdel-Wahid, L.; Ashmawy, A.M.; Alkareemy, E.A.R. Clinical outcomes and prevalence of Hepatitis E Virus (HEV) among non-AC hepatitis patients in egypt. Infect. Drug Resist. 2021, 14, 59. [Google Scholar] [CrossRef]
- E Araújo, D.C.d.A.; de Oliveira, J.M.; Haddad, S.K.; da Roza, D.L.; de Oliveira Bottino, F.; Faria, S.B.S.C.; Bellíssimo-Rodrigues, F.; Passos, A.D.C. Declining prevalence of hepatitis A and silent circulation of hepatitis E virus infection in southeastern Brazil. Int. J. Infect. Dis. 2020, 101, 17–23. [Google Scholar] [CrossRef]
- Wang, Y.; Wang, S.; Wu, J.; Jiang, Y.; Zhang, H.; Li, S.; Liu, H.; Yang, C.; Tang, H.; Guo, N. Hepatitis E virus infection in acute non-traumatic neuropathy: A large prospective case-control study in China. EBioMedicine 2018, 36, 122–130. [Google Scholar] [CrossRef] [Green Version]
- Bai, M.-J.; Zhou, N.; Dong, W.; Li, G.-X.; Cong, W.; Zhu, X.-Q. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China. Int. J. Infect. Dis. 2018, 71, 42–47. [Google Scholar] [CrossRef] [Green Version]
- Farooqi, H.M.U.; Khalid, M.A.U.; Kim, K.H.; Lee, S.R.; Choi, K.H. Real-time physiological sensor-based liver-on-chip device for monitoring drug toxicity. J. Micromech. Microeng. 2020, 30, 115013. [Google Scholar] [CrossRef]
- Wong, R.J.; Cheung, R.; Gish, R.G.; Chitnis, A.S. Prevalence of hepatitis E infection among adults with concurrent chronic liver disease. J. Viral Hepat. 2021, 28, 1643–1655. [Google Scholar] [CrossRef] [PubMed]
Variable | No. of Subjects | Prevalence Percentage of Anti-HEV IgG |
---|---|---|
Age (years) | ||
Less than 10 | 69 | 1.08 |
10–20 | 113 | 3.23 |
21–30 | 118 | 4.92 |
31–40 | 97 | 6.46 |
41–50 | 62 | 2.31 |
51–60 | 57 | 1.23 |
61–70 | 92 | 2.77 |
Above 70 | 42 | 2.00 |
Sex | ||
Male | 444 | 19.23 |
Female | 206 | 4.77 |
History of Viral Hepatitis | ||
No | 552 | 20.31 |
Yes | 98 | 3.69 |
Household Education | ||
Primary | 172 | 5.08 |
Middle | 164 | 4.92 |
High school | 23 | 0.31 |
Graduated | 291 | 13.69 |
Employment Status | ||
Employed | 253 | 12.62 |
Housewife | 89 | 2.31 |
Retired | 88 | 3.69 |
Dependency Index | ||
Family-dependent | 356 | 11.85 |
Non-family-dependent | 294 | 12.15 |
Drinking Water Filtered | ||
No | 204 | 19.38 |
Yes | 446 | 4.62 |
Housing Occupancy | ||
1–5 | 85 | 1.85 |
6–11 | 565 | 22.15 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Farooqi, M.A.; Ahsan, A.; Yousuf, S.; Shakoor, N.; Farooqi, H.M.U. Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi. Livers 2022, 2, 108-115. https://doi.org/10.3390/livers2030009
Farooqi MA, Ahsan A, Yousuf S, Shakoor N, Farooqi HMU. Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi. Livers. 2022; 2(3):108-115. https://doi.org/10.3390/livers2030009
Chicago/Turabian StyleFarooqi, Muhammad Awais, Ali Ahsan, Shazia Yousuf, Noman Shakoor, and Hafiz Muhammad Umer Farooqi. 2022. "Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi" Livers 2, no. 3: 108-115. https://doi.org/10.3390/livers2030009
APA StyleFarooqi, M. A., Ahsan, A., Yousuf, S., Shakoor, N., & Farooqi, H. M. U. (2022). Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi. Livers, 2(3), 108-115. https://doi.org/10.3390/livers2030009